Validation of the German version of the Mediterranean Diet Adherence Screener (MEDAS) questionnaire

Katrin Hebestreit, Maryam Yahiaoui-Doktor, Christoph Engel, Walter Vetter, Michael Siniatchkin, Nicole Erickson, Martin Halle, Marion Kiechle, Stephan C Bischoff, Katrin Hebestreit, Maryam Yahiaoui-Doktor, Christoph Engel, Walter Vetter, Michael Siniatchkin, Nicole Erickson, Martin Halle, Marion Kiechle, Stephan C Bischoff

Abstract

Background: Health benefits of the Mediterranean Diet (MD) have been shown in different at-risk populations. A German translation of the Mediterranean Diet Adherence Screener (MEDAS) from the PREvención con DIeta MEDiterránea (PREDIMED) consortium was used in the LIBRE study, investigating effects of lifestyle-intervention on women with BRCA1/2 mutations. The purpose of the present study is to validate the MEDAS German version.

Methods: LIBRE is a multicentre (three university hospitals during this pilot phase), unblinded, randomized, controlled clinical trial. Women with a BRCA1/2 mutation of age 18 or over who provided written consent were eligible for the trial. As part of the assessment, all were given a full-length Food Frequency Questionnaire (FFQ) and MEDAS at baseline and after 3 months. Data derived from FFQ was compared to MEDAS in order to evaluate agreement or concordance between the two questionnaires. Additionally, the association of dietary intake biomarkers in the blood (β-carotene, omega-3, omega-6 and omega-9 fatty acids and high-sensitivity C-reactive protein (hsCRP)) with some MEDAS items was analyzed using t-Tests and a multivariate regression.

Results: The participants of the LIBRE pilot study were 68 in total (33 Intervention, 35 Control). Only participants who completed both questionnaires were included in this analysis (baseline: 66, month three: 54). The concordance between these two questionnaires varied between the items (Intraclass correlation coefficient of 0.91 for pulses at the highest and -0.33 for sugar-sweetened drinks). Mean MEDAS scores (sum of all items) were 9% higher than their FFQ counter-parts at baseline and 15% after 3 months. Higher fish consumption (at least 3 portions) was associated with lower omega-6 fatty acid levels (p = 0.026) and higher omega-3 fatty acid levels (p = 0.037), both results being statistically significant.

Conclusions: We conclude that the German MEDAS in its current version could be a useful tool in clinical trials and in practice to assess adherence to MD.

Trial registration: ClinicalTrials.gov , registered on March 12, 2014, identifier: NCT02087592 . World Health Organization Trial Registration, registered on 3 August 2015, identifier: NCT02087592 .

Keywords: BRCA1/2; Food frequency; Hereditary breast cancer; Mediterranean diet adherence; Validation.

Figures

Fig. 1
Fig. 1
Bland-Altman plots showing the differences between the MEDAS score aggregated from MEDAS and FFQ questionnaires at baseline and after 3 months. The red dashed and dotted lines indicate the mean bias and its 95% confidence interval. The blue dashed and dotted lines depict limits of agreement and their 95% confidence intervals
Fig. 2
Fig. 2
Association of vegetable consumption (question 3 of the MEDAS questionnaire) and fruit consumption (question 4 of the MEDAS questionnaire) with β-carotene; and association of fish consumption (question 10 of the MEDAS questionnaire) with omega-6 fatty acids and omega-3 fatty acids after 3 months (V1) [0 = 0 point in the MEDAS question; 1 = 1 point in the MEDAS question]. The p-value was calculated using the t-test

References

    1. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279–1290. doi: 10.1056/NEJMoa1200303.
    1. Ruiz-Canela M, Estruch R, Corella D, Salas-Salvado J, Martinez-Gonzalez MA. Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial. JAMA. 2014;311(4):415–417. doi: 10.1001/jama.2013.280618.
    1. Damasceno NR, Sala-Vila A, Cofan M, Perez-Heras AM, Fito M, Ruiz-Gutierrez V, Martinez-Gonzalez MA, Corella D, Aros F, Estruch R, et al. Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at high cardiovascular risk. Atherosclerosis. 2013;230(2):347–353. doi: 10.1016/j.atherosclerosis.2013.08.014.
    1. Domenech M, Roman P, Lapetra J, de la Corte FJ G, Sala-Vila A, de la Torre R, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Lamuela-Raventos RM, et al. Mediterranean diet reduces 24-hour ambulatory blood pressure, blood glucose, and lipids: one-year randomized, clinical trial. Hypertension. 2014;64(1):69–76. doi: 10.1161/HYPERTENSIONAHA.113.03353.
    1. Esposito K, Maiorino MI, Petrizzo M, Bellastella G, Giugliano D. The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: follow-up of a randomized trial. Diabetes Care. 2014;37(7):1824–1830. doi: 10.2337/dc13-2899.
    1. Valls-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, de la Torre R, Martinez-Gonzalez MA, Martinez-Lapiscina EH, Fito M, Perez-Heras A, Salas-Salvado J, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med. 2015;175(7):1094–1103. doi: 10.1001/jamainternmed.2015.1668.
    1. Buckland G, Agudo A, Lujan L, Jakszyn P, Bueno-de-Mesquita HB, Palli D, Boeing H, Carneiro F, Krogh V, Sacerdote C, et al. Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European prospective Investigation into cancer and nutrition (EPIC) cohort study. Am J Clin Nutr. 2010;91(2):381–390. doi: 10.3945/ajcn.2009.28209.
    1. Bamia C, Lagiou P, Buckland G, Grioni S, Agnoli C, Taylor AJ, Dahm CC, Overvad K, Olsen A, Tjonneland A, et al. Mediterranean diet and colorectal cancer risk: results from a European cohort. Eur J Epidemiol. 2013;28(4):317–328. doi: 10.1007/s10654-013-9795-x.
    1. Buckland G, Ros MM, Roswall N, Bueno-de-Mesquita HB, Travier N, Tjonneland A, Kiemeney LA, Sacerdote C, Tumino R, Ljungberg B, et al. Adherence to the Mediterranean diet and risk of bladder cancer in the EPIC cohort study. Int J Cancer. 2014;134(10):2504–2511. doi: 10.1002/ijc.28573.
    1. Fernandez-Ballart JD, Pinol JL, Zazpe I, Corella D, Carrasco P, Toledo E, Perez-Bauer M, Martinez-Gonzalez MA, Salas-Salvado J, Martin-Moreno JM. Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr. 2010;103(12):1808–1816. doi: 10.1017/S0007114509993837.
    1. Schröder H, Fito M, Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Lamuela-Raventos R, Ros E, Salaverria I, Fiol M, et al. A short screener is valid for assessing Mediterranean diet adherence among older spanish men and women. J Nutr. 2011;141(6):1140–1145. doi: 10.3945/jn.110.135566.
    1. Martinez-Gonzalez MA, Garcia-Arellano A, Toledo E, Salas-Salvado J, Buil-Cosiales P, Corella D, Covas MI, Schroder H, Aros F, Gomez-Gracia E, et al. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial. PLoS One. 2012;7(8):e43134. doi: 10.1371/journal.pone.0043134.
    1. Kiechle M, Engel C, Berling A, Hebestreit K, Bischoff S, Dukatz R, Gerber WD, Siniatchkin M, Pfeifer K, Grill S, et al. Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study) Pilot Feasibility Stud. 2016;2:74. doi: 10.1186/s40814-016-0114-7.
    1. Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105(11):812–822. doi: 10.1093/jnci/djt095.
    1. Friedenreich CM. The role of physical activity in breast cancer etiology. Semin Oncol. 2010;37(3):297–302. doi: 10.1053/j.seminoncol.2010.05.008.
    1. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302(5645):643–646. doi: 10.1126/science.1088759.
    1. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P. Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8(2):94–104. doi: 10.1111/j.1524-4733.2005.04054.x.
    1. Kroke A, Klipstein-Grobusch K, Voss S, Möseneder J, Thielecke F, Noack R, Boeing H. Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and nutrition (EPIC) study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods. Am J Clin Nutr. 1999;70(4):439–447.
    1. Boeing H, Bohlscheid-Thomas S, Voss S, Schneeweiss S, Wahrendorf J. The relative validity of vitamin intakes derived from a food frequency questionnaire compared to 24-hour recalls and biological measurements: results from the EPIC pilot study in Germany. European prospective Investigation into cancer and nutrition. Int J Epidemiol. 1997;26(1):S82–S90. doi: 10.1093/ije/26.suppl_1.S82.
    1. Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European prospective Investigation into cancer and nutrition. Int J Epidemiol. 1997;26(S1):S59–S70. doi: 10.1093/ije/26.suppl_1.S59.
    1. Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J. Reproducibility and relative validity of energy and macronutrient intake of a food frequency questionnaire developed for the German part of the EPIC project. European prospective Investigation into cancer and nutrition. Int J Epidemiol. 1997;26:S71–S81. doi: 10.1093/ije/26.suppl_1.S71.
    1. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6(4):284–290. doi: 10.1037/1040-3590.6.4.284.
    1. Willett W, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr. 1995;61(6 Suppl):1402S–1406S.
    1. Thurnhofer S, Lehnert K, Vetter W. Exclusive quantification of methyl-branched fatty acids and minor 18:1-isomers in foodstuff by GC/MS in the SIM mode using 10, 11-dichloroundecanoic acid and fatty acid ethyl esters as internal standards. Eur Food Res Technol. 2007;226(5):975–983. doi: 10.1007/s00217-007-0619-7.
    1. Thurnhofer S, Vetter W. Application of ethyl esters and d3-methyl esters as internal standards for the gas chromatographic quantification of transesterified fatty acid methyl esters in food. J Agric Food Chem. 2006;54(9):3209–3214. doi: 10.1021/jf053022j.
    1. Kitamura Y, Tanaka K, Kiyohara C, Hirohata T, Tomita Y, Ishibashi M, Kido K. Relationship of alcohol use, physical activity and dietary habits with serum carotenoids, retinol and alpha-tocopherol among male Japanese smokers. Int J Epidemiol. 1997;26(2):307–314. doi: 10.1093/ije/26.2.307.
    1. Wahrburg U, Kratz M, Cullen P. Mediterranean diet, olive oil and health. Eur J Lipid Sci Technol. 2002;104(9–10):698–705. doi: 10.1002/1438-9312(200210)104:9/10<698::AID-EJLT698>;2-A.
    1. Odermatt A. The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol Ren Physiol. 2011;301(5):F919–F931. doi: 10.1152/ajprenal.00068.2011.
    1. Barcelo F, Perona JS, Prades J, Funari SS, Gomez-Gracia E, Conde M, Estruch R, Ruiz-Gutierrez V. Mediterranean-style diet effect on the structural properties of the erythrocyte cell membrane of hypertensive patients: the Prevencion con Dieta mediterranea study. Hypertension. 2009;54(5):1143–1150. doi: 10.1161/HYPERTENSIONAHA.109.137471.
    1. Takkunen M, Agren J, Kuusisto J, Laakso M, Uusitupa M, Schwab U. Dietary fat in relation to erythrocyte fatty acid composition in men. Lipids. 2013;48(11):1093–1102. doi: 10.1007/s11745-013-3832-0.
    1. Kiechle M, Engel C, Berling A, Hebestreit K, Bischoff SC, Dukatz R, Siniatchkin M, Pfeifer K, Grill S, Yahiaoui-Doktor M, et al. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial. Trials. 2016;17:368. doi: 10.1186/s13063-016-1504-0.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner